The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment - Lv, Jiawei; Wei, Yuan; Yin, Jian-Hua; Chen, Yu-Pei; Zhou, Guan-Qun; Wei, Chen; Liang, Xiao-Yu; Zhang, Yuan; Zhang, Cui-Juan; He, Shi-Wei; He, Qing-Mei; Huang, Zhuo-Li; et al. (Nature medicine, 2023)
Keywords: 631/250; 631/67; Antitumor activity; Biomarkers; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer Research; CD8 antigen; Chemotherapy; Cisplatin; Combined treatment; Cytotoxicity; Gemcitabine; Gene sequencing; Germinal centers; Health services; Immune response; Immune system; Immunotherapy; Infectious Diseases; Lymphocytes; Lymphocytes B; Lymphocytes T; Major histocompatibility complex; Metabolic Diseases; Microenvironments; Molecular Medicine; Nasopharyngeal carcinoma; Neurosciences; Patients; Throat cancer; Toll-like receptors; Tumors